Clinical Trials on Breast Cancer in Japan
Total 1168 results
-
TakedaCompletedPremenopausal Breast CancerJapan
-
Tokyo Medical UniversityTokyo University; Saint Luca International HospitalCompleted
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Metastatic CancerJapan
-
Nippon Kayaku Co., Ltd.CompletedBreast Cancer Nos Metastatic RecurrentJapan
-
Eli Lilly and CompanyCompletedBreast Cancer | Metastatic Breast CancerJapan
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
AgendiaOsaka General Medical CenterCompleted
-
Tokyo Medical and Dental UniversityRecruitingBreast Cancer | Metastatic Breast Cancer | OligometastasisJapan
-
National Cancer Center, JapanH.U. Group Research Institute G.K.RecruitingHER2-positive Breast CancerJapan
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Japanese Foundation for Cancer ResearchChugai PharmaceuticalActive, not recruiting
-
Kyoto Breast Cancer Research NetworkCompleted
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Chugai PharmaceuticalCompleted
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
Comprehensive Support Project for Oncology ResearchCompleted
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Kyoto Prefectural University of MedicineActive, not recruiting
-
AstraZenecaCompleted
-
Eisai Co., Ltd.CompletedBreast Cancer | HER2-negative Breast CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminated
-
Kyoto Breast Cancer Research NetworkTerminated
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminated
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
AstraZenecaCompleted
-
Anwar Ali Ahmad AlameerCompletedEffect of Health Education Regarding Screening Tools of Breast CancerSaudi Arabia
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Eisai Co., Ltd.Completed
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Comprehensive Support Project for Oncology ResearchNovartis PharmaceuticalsCompleted
-
Translational Research Center for Medical Innovation...Completed
-
Eisai Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
SanofiActive, not recruiting
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Translational Research Center for Medical Innovation...Kyoto Breast Cancer Research NetworkCompleted
-
R-PharmCompleted
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Tohoku UniversityCompleted
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterTerminatedBreast CancerUnited States, Japan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedBreast Cancer | Neoplasm MetastasisJapan